Helpful Information from Industry

The information contained on this page is provided by the respective companies noted. It does not necessarily reflect the Society’s viewpoint and may redirect the user to a third-party site. ASE has posted this content on ContrastZone as a convenient way to access multiple pieces of information in one place, in alignment with our Society’s goal to provide resources and education to enhance the access to and quality in cardiovascular ultrasound.

Bracco Diagnostics

December 2019: LUMASON is now approved for pediatric patients with suboptimal echocardiograms.

September 2019: Test your skills at, an interactive and educational program that illustrates the value of ultrasound contrast.

January 2017: The FDA removes the contraindication for use of Bracco Diagnostics Inc.’s LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use, in patients with cardiac shunts

March 2016: LUMASON is now FDA approved for use in ultrasonography of the liver

Please read the press release and prescribing information for more information.

Lumason Formulary Kit: includes Lumason Product Monograph, Safety Data Sheet, FDA Approval Letter, and Prescribing Information

Lumason Brochure: overview of products (Updated Brochure coming soon)

2019 LUMASON® Reimbursement Guide


November 2015: Lumason® approved for reimbursement by CMS
To learn more about how to code Bracco’s new ultrasound contrast agent, visit here and read the press release here.

GE Healthcare

GE ultrasound contrast agent Optison gets FDA OK for label change

Optison Dosing, Handling, & Administration Training Video (updated link coming soon)

Optison Case Study Video (it is highly suggested that Google Chrome is used with this link)

Quick Reference Guide for Using Optison  (updated link coming soon)

Preparation and Administration Guidelines  (updated link coming soon)

Lantheus Medical Imaging

DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension
Lantheus Medical Imaging, Inc.

DEFINITY® Prescribing Information

On-Demand Webinars

Clinical Case Studies

Dosing and Administration

Image Optimization



ASE Headquarters – COVID-19 Update

Beginning March 26, 2020, the county where the ASE Headquarters is located is under a government order to “Stay at Home” due to the spread of the coronavirus. These “Stay at Home” recommendations continue to be in effect and depend on the infection rates in the County/State. ASE will keep all but essential personnel telecommuting until a time when it is judged safe to return to work. We are not suspending or closing operations; our employees will remain working and providing excellent customer service to our members and the cardiovascular ultrasound community. However, ASE will slightly modify its official open hours to 9 AM – 4 PM Eastern TimeMonday-Friday. Should you need to get in touch with a staff person, call our main office at 919-861-5574 and a phone list by department will be available. A staff directory is also available here. All general questions can also be sent through Thank you and our best wishes for your continued safety.